Nutex Health, Inc.

Seeking Alpha•8/12/2026

Nutex Health: A 'Strong Buy' Amid Margin Expansion, Regulatory Tailwinds (Upgrade)

Seeking Alpha•8/7/2026

Nutex Health Schedules 2026 Second Quarter Financial Results Release and Conference Call

HOUSTON, July 21, 2026 /PRNewswire/ — Nutex Health, Inc. (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced that it plans to file its Form 10-Q for the second fiscal quarter ended June 30, 2026, on Thursday, Aug. 6, 2026, after the market close. The Company will also issue a corresponding press release summarizing financial results on the same day.

Seeking Alpha•7/1/2026

Nutex Health Has A Healthy Pulse And Shows Strong Signs Of Life For Further Gains

Nutex Health is rated Buy, with a DCF-based price target of $199.31, offering 19.8% upside from $166.40. NUTX's revenue surged from $247.6M in FY2023 to $880.0M TTM ended March 31, 2026, driven by effective use of the No Surprises Act's IDR process. Liquidity and leverage metrics have improved, with debt-to-equity falling below 1.0 and the current ratio at 3.1 in the TTM period.

GlobeNewsWire•6/9/2026

Kuehn Law Encourages Investors of Nutex Health, Inc. to Contact Law Firm

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Nutex Health, Inc. (NASDAQ: NUTX) breached their fiduciary duties to shareholders.